In­ter­cept re­tools C-suite with a pair of new­com­ers; Charles Ryan moves past Alzheimer's flops with an­oth­er CEO chal­lenge

→ Ja­son Cam­pagna and Sandip Ka­pa­dia were two ex­ecs who punched their tick­ets out of In­ter­cept as things went pear-shaped, and the tee­ter­ing NASH biotech has found their re­place­ments as CMO Michelle Berrey and CFO An­drew Saik take over their po­si­tions. Berrey, the ex-pres­i­dent and CEO at Chimerix, was Phar­mas­set’s CMO from 2007-12. Just be­fore her Phar­mas­set days, she had been with Glax­o­SmithK­line as VP, vi­ral dis­eases, clin­i­cal phar­ma­col­o­gy & dis­cov­ery med­i­cine. Berrey will al­so be In­ter­cept’s pres­i­dent of R&D in ad­di­tion to CMO. SVP Gail Cawk­well had been pinch-hit­ting af­ter Cam­pagna’s de­par­ture and sub­se­quent move to Q32 Bio.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER